Highlights at this year’s SNM include:
IQ•SPECT. (Works in Progress) IQ•SPECT is Siemens newest Symbia® feature that enables a comprehensive cardiac evaluation including perfusion, attenuation correction and calcium scoring in just five minutes (based on preliminary data).
HD•PET. Siemens HD•PET is the world’s first and only high-definition PET technology to offer consistently sharper and clearly defined images across the entire field of view. The clarity achieved by HD•PET is the result of a unique and proprietary technology that optimizes the elements of image uniformity, resolution and contrast.
Symbia® E. One of the newest additions to the Symbia family of SPECT and SPECT•CT systems, Symbia E provides users with a SPECT imager that can lead to improved clinical confidence, reliability and versatility.
Imaging Biomarkers. While currently the largest distributor of PET radiopharmaceuticals in the U.S. and aggressively expanding internationally into countries and regions, such as India, the United Kingdom, Korea and Australia, Siemens is also making inroads into developing new imaging biomarkers.
This press kit provides news and background information on how Siemens molecular imaging technologies are helping physicians detect diseases earlier, monitor treatments more effectively and devise personalized therapies.